Jefferies lowers Heron Therapeutics stock price target on oncology franchise decline
NegativeFinancial Markets

Jefferies lowers Heron Therapeutics stock price target on oncology franchise decline
Jefferies has reduced its stock price target for Heron Therapeutics due to a decline in its oncology franchise. This adjustment reflects concerns about the company's performance in the oncology sector, which may impact investor confidence.
— via World Pulse Now AI Editorial System





